Tilray Brands (NASDAQ:TLRY) Stock Price Down 11.8% Following Insider Selling

Tilray Brands, Inc. (NASDAQ:TLRY)’s stock price was down 11.8% on Thursday following insider selling activity. The company traded as low as $6.82 and last traded at $6.94. Approximately 42,291,145 shares changed hands during mid-day trading, an increase of 852% from the average daily volume of 4,444,306 shares. The stock had previously closed at $7.87.

Specifically, Director David G. Hopkinson sold 33,556 shares of the business’s stock in a transaction on Tuesday, April 21st. The stock was sold at an average price of $6.94, for a total value of $232,878.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Analysts Set New Price Targets

Several research analysts have recently commented on TLRY shares. ATB Cormark Capital Markets reduced their price target on Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating for the company in a research report on Thursday, April 2nd. Roth Mkm raised Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 price target for the company in a research report on Thursday, April 2nd. Wall Street Zen raised Tilray Brands from a “sell” rating to a “hold” rating in a research report on Saturday, March 21st. Zacks Research raised Tilray Brands from a “strong sell” rating to a “hold” rating in a research report on Wednesday, February 11th. Finally, Canaccord Genuity Group started coverage on Tilray Brands in a research report on Tuesday, January 27th. They set a “hold” rating on the stock. Three research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $11.50.

Tilray Brands News Roundup

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Federal reclassification to Schedule III is being treated as a landmark regulatory move that materially improves the tax and cash-flow outlook for many U.S. cannabis operators, driving broad sector buying (sector lift benefits liquid names like TLRY). Read More.
• Positive Sentiment: MarketBeat analysis emphasizes that removing the 280E tax burden for qualifying U.S. plant-touching operators creates a large, non‑dilutive cash-flow tailwind across the sector — a powerful narrative that drew buying interest into cannabis equities. Read More.
• Positive Sentiment: Tilray issued statements positioning the company for U.S. expansion (Tilray Medical) and promoted consumer/beverage momentum (BrewDog USA product launches), which supported the initial bullish sentiment. Read More.
• Positive Sentiment: Elevated bullish flow — unusually large pre/post-market call buying and analyst notes (Roth Capital bullish thesis) amplified the early rally and brought speculative volume into TLRY. Read More.
• Neutral Sentiment: Trading experienced a mechanical LULD pause during the volatility; these halts reflect fast moves but do not change the underlying drivers or fundamentals. (No external link.)
• Neutral Sentiment: Important nuance — MarketBeat highlights that Tilray is not a traditional U.S. plant‑touching MSO and therefore does not capture the 280E tax saving the way U.S. MSOs do; TLRY gains may be more of a “sympathy” trade. Read More.
• Negative Sentiment: “Sell‑the‑news” intraday reversal and renewed dilution worries: reporting shows TLRY ran up then reversed as traders took profits, and investors flagged an April SEC prospectus supplement for an at‑the‑market offering (up to ~$180M) that raises dilution/funding concerns. Read More.
• Negative Sentiment: Insider selling: a director disclosed a ~33,556‑share sale last week, which some investors interpret as a cautionary sign amid heightened volatility. Read More.
• Negative Sentiment: Intraday momentum reversals across the sector (soared‑then‑sank coverage) indicate the move is headline‑sensitive and subject to rapid profit‑taking; that raises short‑term risk for momentum traders. Read More.

Tilray Brands Trading Down 11.8%

The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.66 and a current ratio of 2.79. The company has a 50 day simple moving average of $7.04 and a two-hundred day simple moving average of $9.53. The firm has a market cap of $808.85 million, a PE ratio of -0.51 and a beta of 2.00.

Tilray Brands (NASDAQ:TLRY) last posted its quarterly earnings results on Wednesday, April 1st. The company reported ($0.24) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.10). The firm had revenue of $206.73 million for the quarter, compared to analysts’ expectations of $201.35 million. Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. During the same quarter in the previous year, the firm posted ($0.87) EPS. Analysts expect that Tilray Brands, Inc. will post -0.55 EPS for the current fiscal year.

Institutional Trading of Tilray Brands

Several large investors have recently added to or reduced their stakes in TLRY. AQR Capital Management LLC grew its stake in Tilray Brands by 1,839.7% during the 1st quarter. AQR Capital Management LLC now owns 607,054 shares of the company’s stock valued at $399,000 after purchasing an additional 575,757 shares during the last quarter. XTX Topco Ltd purchased a new stake in shares of Tilray Brands in the second quarter worth about $112,000. Cerity Partners LLC boosted its stake in shares of Tilray Brands by 98.5% in the second quarter. Cerity Partners LLC now owns 92,560 shares of the company’s stock worth $38,000 after buying an additional 45,929 shares during the last quarter. Ausdal Financial Partners Inc. purchased a new stake in shares of Tilray Brands in the second quarter worth about $939,000. Finally, Bank of America Corp DE boosted its stake in shares of Tilray Brands by 26.5% in the second quarter. Bank of America Corp DE now owns 311,810 shares of the company’s stock worth $129,000 after buying an additional 65,379 shares during the last quarter. Hedge funds and other institutional investors own 9.35% of the company’s stock.

About Tilray Brands

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.